Skip to Main Content

Paper Details

JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AML.
Blood
81
2017
Author NameAffiliation
David TamboreroResearch Unit on Biomedical Informatics, Universitat Pompeu Fabra
Jing TangInstitute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki
Tero AittokallioInstitute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki
Olli KallioniemiInstitute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki
Krister WennerbergInstitute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki
  • 1 - 5

Datasets